In Elkind-Hirsch et al., DHEA-S levels decreased in the SGLT2 inhibitor group when compared to baseline patient parameters; however, the drug effect did not reach statistical significance [ 32 ].
← all excerpts
The Role of Sodium-Glucose Cotransporter-2 Inhibitors in the Treatment of Polycystic Ovary Syndrome: A Review.
1
—
—